___

• 1. Onat A, Kaya A, Akbaş Şimşek T, Şimşek B, Tusun E, Karadeniz Y, et al. Twenty-five years of the TARF study: The 2015 survey, and temporal trends in mortality and loss to follow-up. Turk Kardiyol Dern Ars. 2016; 44(5):365-70. 2. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36(3):959-69. 3. Demir V, Yılmaz S, Ede H, Turan Y. Correlation of Resting Heart Rate with the Severity and Complexity of Coronary Artery Disease: A Single-Center Retrospective Study. Int J Prev Med. 2019; 7;10:104.4. Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014; 19;312(19):2019-27. 5. Fox K, GarciaMA, Ardissino D, Buszman P, Camici PG, Crea F, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006; 27:1341–81. 6. TEMD Obezite, Lipid Metabolizması, Hipertansiyon Çalışma Grubu. Obezite tanı ve tedavi kılavuzu, Türkiye Endokrinoloji ve Metabolizma Derneği 2017; 11-19. [İnternet: Türkiye Endokrinoloji ve Metabolizma Derneği]. Erişim: http://www.temd.org.tr/files/file/OBEZITE_TTK_web.pdf. 7. Demir V, Samet Y, Akboga MK. Association of lymphocyte-monocyte ratio and monocyte-to-high-density lipoprotein ratio with the presence and severity of rheumatic mitral valve stenosis. Biomark Med. 2017; 11(8):657-63. 8. Alp Ç, Dogru MT, Karadeniz M, Sarak T, Demir V, Çelik Y, et al. Serum pentraxin-3 levels and flow-mediated dilation in dipper and non-dipper hypertension. J Clin Lab Anal. 2019; 33(3):e22718. 9. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management. Part I. Mayo Clin Proc. 2009; 84:917–38. 10. Ahmed MH, Awadalla H, Elmadhoun WM, Osman M, Noor SK, Almobarak AO. Prevalence and risk factors for acute coronary syndrome among sudanese individuals with diabetes: a population-based study. Cardiol Res. 2017; 8:184–9. 11. Larifla L, Armand C, Velayoudom-Cephise FL, Weladji G, Michel CT, Blanchet-Deverly A, et al. Distribution of coronary artery disease severity and risk factors in Afro-Caribbeans. Arch Cardiovasc Dis. 2014; 107(4):212-8. 12. Delp MD, Behnke BJ, Spier SA, Wu G, Muller-Delp JM. Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles. J Physiol. 2008; 15;586(4):1161-8. 13. Veeranna V, Pradhan J, Niraj A, Fakhry H, Afonso L. Traditional cardiovascular risk factors and severity of angiographic coronary artery disease in the elderly. Prev Cardiol. 2010;13(3):135-40. 14. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem J. 1991; 1;277 ( Pt 1):133-8. 15. Rival J, Riddle JM, Stein PD. Effects of chronic smoking on platelet function. Thromb Res. 1987; 45:75. 16. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 23;339(4):229-34. 17. Fuster V, Alexander RW O’Rourke R: Hurst’s The Heart. 10. Baskısının Türkçe çevirisi. And Danışmanlık Eğitim Yayıncılık ve Organizasyon Ltd. Şti.1. Basım. 2002; p. 1065-109.